Table 4.

Name list of the nanoformulations and their corresponding therapeutic applications.

S. No.	Name of the Nanoformulation	Formulation Ingredients and Method	Application	References
1	Cur@CRN	Nanocomposites containing Cur and ι-Carrageenan using emulsion technique	Enhanced stability, oral bioavailability, antioxidant and anti-inflammatory effects	[207]
2	CUR-Gel-HAp	Encapsulation of curcumin into the hydrophilic network of gelatin (Gel) and hydroxyapatite (HAp) by colloidal suspension	Enhanced cytotoxicity towards human lung cancer cells (A549)	[9]
3	Nanocurcumin	Nanomicelle with an average size of 50 nm containing curcumin	Enhanced antioxidant and anti-inflammatory effects against LPS-induced coliform mastitis in rat model	[208]
4	Curcumin nanoparticle	Curcumin loaded in poly lactic-co-glycolic acid nanoparticles with an average size of ~90 ± 10 nm by green surfactant-based synthesis	Enhanced solubility, photo-stability, antibiofilm activity and cytotoxicity towards HepG2 cells	[209]
5	CUR-loaded NC	Curcumin-loaded polymeric nanocapsules	Enhanced antiangiogenic, non-teratogenic and antioxidant effects in chick embryo model.	[210]
6	MSN-HA-C	Curcumin loaded in nanohybrid composed of mesoporous silica nanoparticle (MSN) and hyaluronic acid (HA) with an average size of ~75 nm	In vivo and in vitro anti-breast cancer activity	[211]
7	Fe@Au-CU-CS-FA NP’s	Nanoencapsulation comprised of folic acid, gold, curcumin, chitosan and iron synthesised by microemulsion method	Cytotoxic effect on lung cancer cells	[212]
8	SD-CUR	A core–shell solid dispersion composed of curcumin-loaded micelles self-assembled from disodium glycyrrhizin (Na2GA), coated with pectin and tannic acid	Enhanced bioavailability and antihyperlipidemic activity	[213]
9	SNLYZ-Cur	The nanoconjugate SNLYZ-Cur composed of curcumin surface-conjugated on self-assembled lysozyme nanoparticle with an average size of ~120 nm	Antibacterial, antioxidant and anticancer activity against multiple cancer cell lines such as HeLa, MCF-7, MDAMB-231 and MG 63	[214]
10	Cur-CasNPs	Encapsulation of curcumin in casein nanoparticles	Enhanced bioavailability and anticancer activity against MCF-7 cell lines	[215]
11	CDD-CANPs	Encapsulation of curcumin diethyl disuccinate (CDD) in chitosan–alginate nanoparticles (CANPs)	High chemical stability upon UV light exposure, fivefold enhanced bioavailability and anticancer activity against HepG2 cell lines	[216]
12	Cur NE-CLA-n-3FA	Nanoemulsions containing curcumin stabilized with mono- and diacylglycerols structured with conjugated linoleic acid (CLA) and n-3 fatty acids (n-3FA)	Greater bioavailability	[217]
13	Cur-C3-CNPs	Nanoparticle composed of curcumin-C3 complex (curcumin, demethoxycurcumin and isdemethoxycurcumin) encapsulated in chitosan	Antioxidant and antibacterial activity	[12]
14	CLL	Nanoliposomes (formulated from salmon, rapeseed and soya lecithin) comprising of curcumin encapsulated in chitosan	Increased bioavailability and anticancer activity against MCF-7 breast cancer cell lines	[218]
15	Cur-BR liposome	Nanoliposome containing curcumin and bromocriptine synthesized by thin-film method	In vitro anticancer activity against lung cancer cells by induction of apoptosis	[219]
16	LRA-CS-CUR hydrogel	A composite hydrogel containing lotus root amylopectin (LRA)-chitosan (CS) in the ratio of 3:2 at pH 4.0 with an average size of 410.3 nm	Enhanced stability in stomach and sustained release in small intestine	[220]
17	Chitosan-PEG-Cur-hydrogel	Hydrogel comprising of chitosan, polyethylene glycol and curcumin using microwave technology at frequency of 2450 MHz, 500 Watt and 120 s time.	In vivo open incision wound healing activity	[221]